Literature DB >> 21699769

Enhanced surveillance during a large outbreak of bloody diarrhoea and haemolytic uraemic syndrome caused by Shiga toxin/verotoxin-producing Escherichia coli in Germany, May to June 2011.

M Wadl1, T Rieck, M Nachtnebel, B Greutélaers, M an der Heiden, D Altmann, W Hellenbrand, M Faber, C Frank, B Schweickert, G Krause, J Benzler, T Eckmanns.   

Abstract

Germany has a well established broad statutory surveillance system for infectious diseases. In the context of the current outbreak of bloody diarrhoea and haemolytic uraemic syndrome caused by Shiga toxin/ verotoxin-producing Escherichia coli in Germany it became clear that the provisions of the routine surveillance system were not sufficient for an adequate response. This article describes the timeline and concepts of the enhanced surveillance implemented during this public health emergency.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21699769     DOI: 10.2807/ese.16.24.19893-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  12 in total

1.  Timeliness of surveillance during outbreak of Shiga Toxin-producing Escherichia coli infection, Germany, 2011.

Authors:  Mathias Altmann; Anke Spode; Doris Altmann; Maria Wadl; Justus Benzler; Tim Eckmanns; Gerard Krause; Matthias An der Heiden
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

2.  Investigation of travel-related cases in a multinational outbreak: example of the Shiga-toxin producing E. coli outbreak in Germany, May-June 2011.

Authors:  I Devaux; C Varela-Santos; L Payne-Hallström; J Takkinen; C Bogaardt; D Coulombier
Journal:  Epidemiol Infect       Date:  2015-04-24       Impact factor: 4.434

3.  Identifying risk factors for shiga toxin-producing Escherichia coli by payment information.

Authors:  Hendrik Wilking; Udo Götsch; Helma Meier; Detlef Thiele; Mona Askar; Manuel Dehnert; Christina Frank; Angelika Fruth; Gérard Krause; Rita Prager; Klaus Stark; Boris Böddinghaus; Oswald Bellinger; René Gottschalk
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

Review 4.  Outbreaks of virulent diarrheagenic Escherichia coli--are we in control?

Authors:  Dirk Werber; Gérard Krause; Christina Frank; Angelika Fruth; Antje Flieger; Martin Mielke; Lars Schaade; Klaus Stark
Journal:  BMC Med       Date:  2012-02-02       Impact factor: 8.775

5.  A concept for routine emergency-care data-based syndromic surveillance in Europe.

Authors:  A Ziemann; N Rosenkötter; L Garcia-Castrillo Riesgo; S Schrell; B Kauhl; G Vergeiner; M Fischer; F K Lippert; A Krämer; H Brand; T Krafft
Journal:  Epidemiol Infect       Date:  2014-01-24       Impact factor: 4.434

Review 6.  Shiga toxin-producing Escherichia coli: factors involved in virulence and cattle colonization.

Authors:  Analía Inés Etcheverría; Nora Lía Padola
Journal:  Virulence       Date:  2013-04-15       Impact factor: 5.882

7.  Meeting the International Health Regulations (2005) surveillance core capacity requirements at the subnational level in Europe: the added value of syndromic surveillance.

Authors:  Alexandra Ziemann; Nicole Rosenkötter; Luis Garcia-Castrillo Riesgo; Matthias Fischer; Alexander Krämer; Freddy K Lippert; Gernot Vergeiner; Helmut Brand; Thomas Krafft
Journal:  BMC Public Health       Date:  2015-02-07       Impact factor: 3.295

8.  Acute gastrointestinal illness in adults in Germany: a population-based telephone survey.

Authors:  H Wilking; H Spitznagel; D Werber; C Lange; A Jansen; K Stark
Journal:  Epidemiol Infect       Date:  2013-02-01       Impact factor: 4.434

9.  Success Factors of European Syndromic Surveillance Systems: A Worked Example of Applying Qualitative Comparative Analysis.

Authors:  Alexandra Ziemann; Anne Fouillet; Helmut Brand; Thomas Krafft
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

10.  Management of Food-Related Diarrhea Outbreak in the Emergency Department: Lessons Learned from the German STEC O104:H4 Epidemic.

Authors:  Friedhelm Sayk; Niels Henrik Asselborn; Nora Eisemann; Alexander Katalinic; Jörg Metzner; Sebastian Wolfrum; Klaus Fellermann; Johannes Knobloch; Martin Nitschke
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.